<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01104012</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-I/2009/NM-01</org_study_id>
    <secondary_id>2009-A00399-48</secondary_id>
    <nct_id>NCT01104012</nct_id>
  </id_info>
  <brief_title>Validation of Proteomic Analyses for Allergic Asthma and Rhinitis</brief_title>
  <acronym>VAPARA</acronym>
  <official_title>The VAPARA Study: Validation of Proteomic Analyses for Allergic Asthma and Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to verify and validate the intrinsic diagnostic value in terms
      of sensitivity and specificity of proteomic profiles determined during a pre-study for
      discriminating between allergy related asthma and allergy related rhinitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proteomic profile of each patient</measure>
    <time_frame>One day (snapshot)</time_frame>
    <description>The attribution of a proteomic profile as either &quot;asthmatic&quot; or &quot;rhinitis&quot;. Proteomic profiles are determined accordig to the SELDI-TOF method. This is a transversal study validating proteomic profiles as a new diagnostic test.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">133</enrollment>
  <condition>Rhinitis, Allergic</condition>
  <condition>Asthma, Allergic</condition>
  <arm_group>
    <arm_group_label>All patients</arm_group_label>
    <description>Allergy patients, asthma and rhinitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Classification as &quot;asthmatic&quot; or &quot;rhinitis only&quot; via proteomic analysis</intervention_name>
    <description>Proteomic profiles are established for each patient using plasma and serum samples</description>
    <arm_group_label>All patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Classification as &quot;asthmatic&quot; or &quot;rhinitis only&quot; according to a metacholine test</intervention_name>
    <description>A positive metacholine test indicating bronchial hyperresponsiveness is currently our Gold Standard for diagnosing asthma.</description>
    <arm_group_label>All patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma samples are taken on patient inclusion. For the purposes of this study, only
      proteomic profiles via SELDI-TOF will be characterized. Excess serum and plasma will be
      stored in the CHU de Nîmes Biothèque.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The asthma and allergic rhinitis patients included in this study are recruted from the
        Pneumology Departments of the University Hospitals of Nîmes, Marseilles, and Montpellier.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed consent

          -  never-smokers or non-smoking for at least 2 years + &lt; 5 packs per year

          -  capable of understanding the study

          -  patient is affiliated with a social security system

          -  positive skin tests (at least one for Montpellier region pneumoallergens)

          -  treated with nasal or inhaled corticoids, leucotriene receptor antagonists, anti-IgE,
             Theophylline, anti-histamines, sodium cromoglycate, beta-blockers, benzodiazépine,
             oral corticoids: all these treatments must be interrupted for at least 72 hours

        Exclusion Criteria:

          -  Co-morbidities: none; no co-morbidities are accepted

          -  dental infections (any) during the 3 months preceding the study

          -  suspected alcoholism or drug abuse

          -  chronic viral infection (hepatitis, HIV)

          -  patient under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Molinari, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique - Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2010</study_first_submitted>
  <study_first_submitted_qc>April 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2010</study_first_posted>
  <last_update_submitted>March 26, 2015</last_update_submitted>
  <last_update_submitted_qc>March 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

